Key points from article :
Science Corporation, a biotech startup best known for brain-computer interfaces and vision-restoring implants, is now tackling a very different medical challenge: extending the life of organs for transplants and critical care. Founded in 2021 by Max Hodak, a former president of Neuralink, the company is developing a portable organ perfusion system designed to keep organs alive and functional far longer than current technology allows—potentially transforming how transplants are done and how patients with organ failure are supported.
Current machines like ECMO (extracorporeal membrane oxygenation) and traditional perfusion systems are bulky, expensive, and limited in how long they can sustain organs or patients outside the body. Science’s prototype uses integrated sensors, automated controls, and a modular design to monitor and adjust blood flow, oxygenation, pressure, and temperature in real time, aiming for longer viability and easier use than today’s systems. The team has already kept rabbit kidneys alive ex vivo for up to 48 hours and hopes to reach month-long preservation by next spring—well beyond conventional storage times.
Hodak says the effort stems from both personal motivation and a broader vision of “longevity technologies” that improve human health span, linking organ preservation to the company’s earlier neural interface and vision tech work. With substantial venture funding and a growing team, Science Corporation hopes to make organ-preservation tools more accessible and affordable, opening the door to better transplant logistics and new life-support possibilities.
